Skip to content
PsychoGenics Transforming CNS discovery
Solutions
Therapeutic Areas
Sleep & Seizure Disorders
Mental Illnesses
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain Disorders
Rare CNS Disorders
Traumatic Brain Injury & Spinal Cord Injury
Preclinical CNS Services
Behavioral and
In Vivo
Testing
Drug Abuse Liability
EEG Studies
Electrophysiology
Preclinical
Ex Vivo
Sample Biomarker Analysis Services
Immunohistochemistry (IHC) & Histology Services
Microdialysis
Pharmacokinetic & Pharmacodynamic (PK/PD) Services
Receptor Occupancy
In Vivo
AI Platforms
eCube™
NeuroCube®
PhenoCube®
SmartCube®
Emerging Therapies
Cell and Gene Therapies
Microbiome
Psychedelics
About
Our Team
Culture
News
Events
Careers
Our Research
Disease Foundations
Contact Us
Open Search
Search
Solutions
Therapeutic Areas
Sleep & Seizure Disorders
Mental Illnesses
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain Disorders
Rare CNS Disorders
Traumatic Brain Injury & Spinal Cord Injury
Preclinical CNS Services
Behavioral and
In Vivo
Testing
Drug Abuse Liability
EEG Studies
Electrophysiology
Preclinical
Ex Vivo
Sample Biomarker Analysis Services
Immunohistochemistry (IHC) & Histology Services
Microdialysis
Pharmacokinetic & Pharmacodynamic (PK/PD) Services
Receptor Occupancy
In Vivo
AI Platforms
eCube™
NeuroCube®
PhenoCube®
SmartCube®
Emerging Therapies
Cell and Gene Therapies
Microbiome
Psychedelics
About
Our Team
Culture
News
Events
Careers
Our Research
Disease Foundations
Contact Us
Close Menu
Publication
Resources
5 Women Leading the Way in Biotech
Resources
PsychoGenics Introduces eCube, an AI-Driven Platform for Drug Discovery in Neuropsychiatric Disorders
Resources
PsychoGenics launches eCube AI platform for drug discovery
Resources
PsychoGenics Launches AI Platform to Revolutionize Drug Discovery
Resources
PsychoGenics’ SmartCube prompts a reevaluation of CNS drug discovery’
Resources
AI-discovered drug shows ‘enormous potential’ to treat schizophrenia: ‘Real need for better treatment’
Resources
How AI Will Make Our Lives Better (And Worse)
Resources
World Wellbeing Week 2023: Celebrating drug discovery innovation
Resources
This company is using AI to develop drugs. Schizophrenia is its first target
Resources
AI-discovered drug shows ‘enormous potential’ to treat schizophrenia: ‘Real need for better treatment’
Posts navigation
Previous
1
2
3
4
…
15
Next
Partner with us and transform your program
DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS
Get Started